Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.066 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.065 | 0.7 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.063 | 0.7 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.051 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |